Trigger Point Injections for Pelvic Pain
book-chapter
OA: closed
CC0
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
- Chronic Pelvic Pain: Prevalence, Health-Related Quality of Life, and Economic Correlates 1996
- The Use of Botulinum Toxin in the Pelvic Floor for Women with Chronic Pelvic Pain–A New Answer to Old Problems? 2009
- Successful Use of Botulinum Toxin Type A in the Treatment of Refractory Postoperative Dyspareunia 2009
References (32)
- Chronic Pelvic Pain: Prevalence, Health-Related Quality of Life, and Economic Correlates via openalex
- Successful Use of Botulinum Toxin Type A in the Treatment of Refractory Postoperative Dyspareunia via openalex
- The Use of Botulinum Toxin in the Pelvic Floor for Women with Chronic Pelvic Pain–A New Answer to Old Problems? via openalex
- W1531652760 via openalex
- W1963796375 via openalex
- W1964503881 via openalex
- W1966430144 via openalex
- W1967408466 via openalex
- W1975584002 via openalex
- W1980746538 via openalex
- W1982464660 via openalex
- W1994775400 via openalex
- W1995285848 via openalex
- W1997575247 via openalex
- W2006372370 via openalex
- W2016790636 via openalex
- W2048737992 via openalex
- W2061535841 via openalex
- W2073224536 via openalex
- W2076420398 via openalex
- W2080584352 via openalex
- W2107945243 via openalex
- W2108549925 via openalex
- W2111010630 via openalex
- W2137792544 via openalex
- W2146276239 via openalex
- W2159011576 via openalex
- W3011645383 via openalex
- W151844747 via openalex
- W3136846218 via openalex
- W183177669 via openalex
- W944281435 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK